Prostaglandins as modulators of immunity

Goetzl, 1995, Specificity of expression and effects of eicosanoid mediators in normal physiology and human diseases, FASEB J., 9, 1051, 10.1096/fasebj.9.11.7649404

Phipps, 1991, A new view of prostaglandin-E regulation of the immune response, Immunol. Today, 12, 349, 10.1016/0167-5699(91)90064-Z

Smith, 1994, Pharmacology of prostaglandin endoperoxide synthase isozymes 1 and 2, Ann. New York Acad. Sci., 714, 136, 10.1111/j.1749-6632.1994.tb12037.x

Langenbach, 1999, Cyclooxygenase-deficient mice. A summary of their characteristics and susceptibilities to inflammation and carcinogenesis, Ann. New York Acad. Sci., 889, 52, 10.1111/j.1749-6632.1999.tb08723.x

O'Banion, 1999, Cyclooxygenase-2: molecular biology, pharmacology and neurobiology, Crit. Rev. Neurobiol., 13, 45, 10.1615/CritRevNeurobiol.v13.i1.30

Filion, 2001, Molecular cloning and induction of bovine prostaglandin E synthase by gonadotropins in ovarian follicles prior to ovulation in vivo, J. Biol. Chem., 273, 34323, 10.1074/jbc.M103709200

Narumiya, 1994, Prostanoid receptors. Structure, function and distribution, Ann. New York Acad. Sci., 744, 126, 10.1111/j.1749-6632.1994.tb52729.x

Breyer, 2001, Prostanoid receptors: subtypes and signaling, Annu. Rev. Pharmacol. Toxicol., 41, 661, 10.1146/annurev.pharmtox.41.1.661

Weinreb, 2001, Expression of the prostaglandin E(2) [PGE(2)] receptor subtype EP(4) and its regulation by PGE(2) in osteoblastic cell lines and adult rat bone tissue, Bone, 28, 275, 10.1016/S8756-3282(00)00447-6

Tilley, 2001, Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes, J. Clin. Invest., 108, 15, 10.1172/JCI200113416

Bhattacharya, 1999, Localization of functional prostaglandin E2 receptors EP3 and EP4 in the nuclear envelope, J. Biol. Chem., 274, 15719, 10.1074/jbc.274.22.15719

Ruggeri, 2000, Polyamine metabolism in prostaglandin-E2-treated human T lymphocytes, Immunopharmacol. Immunotoxicol., 22, 117, 10.3109/08923970009016410

Choudhry, 1999, PGE2 suppresses mitogen-induced Ca2+ mobilization in T cells, Am. J. Physiol., 277, R1741

Choudhry, 1999, PGE(2)-mediated inhibition of T-cell p59 (fyn) is independent of cAMP, Am. J. Physiol., 277, C302, 10.1152/ajpcell.1999.277.2.C302

Cosme, 2000, Prostanoids in human colonic mucosa: effects of inflammation on PGE(2) receptor expression, Hum. Immunol., 61, 684, 10.1016/S0198-8859(00)00131-2

Mastino, 1992, Induction of apoptosis in thymocytes by prostaglandin E2 in vivo, Dev. Immunol., 2, 263, 10.1155/1992/80863

Pica, 1996, Prostaglandin E2 induces apoptosis in resting immature and mature human lymphocytes: a c-Myc-dependent and Bcl-2-independent associated pathway, J. Pharmacol. Exp. Ther., 277, 1793

Porter, 1999, Prostaglandin E2 inhibits T-cell-activation-induced apoptosis and Fas-mediated cellular cytotoxicity by blockade of Fas-ligand induction, Eur. J. Immunol., 29, 2360, 10.1002/(SICI)1521-4141(199907)29:07<2360::AID-IMMU2360>3.0.CO;2-A

Hilkens, 1996, Modulation of T-cell cytokine secretion by accessory-cell-derived products, Eur. Respir. J. Suppl., 22, 90s

Bloom, 1999, Prostaglandin E2 enhancement of interferon-γ production by antigen-stimulated type 1 helper T cells, Cell. Immunol., 194, 21, 10.1006/cimm.1999.1479

Hendricks, 2000, Prostaglandin E2 is variably induced by bacterial superantigens in bovine mononuclear cells and has a regulatory role for the T-cell proliferative response, Immunobiology, 201, 493, 10.1016/S0171-2985(00)80069-8

Ganapathy, 2000, Regulation of TCR-induced IFN-γ release from islet-reactive non-obese diabetic CD8(+) T cells by prostaglandin E(2) receptor signaling, Int. Immunol., 12, 851, 10.1093/intimm/12.6.851

Garrone, 1994, Regulatory effects of prostaglandin E2 on the growth and differentiation of human B lymphocytes activated through their CD40 antigen, J. Immunol., 152, 4282, 10.4049/jimmunol.152.9.4282

Brown, 1992, Prostaglandin E2 induces apoptosis in immature normal and malignant B lymphocytes, Clin. Immunol. Immunopathol., 63, 221, 10.1016/0090-1229(92)90226-E

Shimozato, 1999, Prostaglandin E(2) and stem-cell factor can deliver opposing signals to B-lymphocyte precursors, Cell. Immunol., 198, 21, 10.1006/cimm.1999.1575

Fedyk, 1997, Prostaglandin receptors of the EP2 and EP4 subtypes regulate B-lymphocyte activation and differentiation to IgE-secreting cells, Adv. Exp. Med. Biol., 433, 153, 10.1007/978-1-4899-1810-9_31

Graf, 1999, Biphenotypic B/macrophage cells express COX-1 and up-regulate COX-2 expression and prostaglandin E(2) production in response to pro-inflammatory signals, Eur. J. Immunol., 29, 3793, 10.1002/(SICI)1521-4141(199911)29:11<3793::AID-IMMU3793>3.0.CO;2-3

Harizi, 2001, Dendritic cells issued in vitro from bone marrow produce PGE(2) that contributes to the immunomodulation induced by antigen-presenting cells, Cell. Immunol., 209, 19, 10.1006/cimm.2001.1785

Kalinski, 1997, Dendritic cells, obtained from peripheral-blood precursors in the presence of PGE2, promote Th2 responses, Adv. Exp. Med. Biol., 417, 363, 10.1007/978-1-4757-9966-8_59

Hinz, 2000, Prostaglandin E(2) upregulates cyclooxygenase-2 expression in lipopolysaccharide-stimulated RAW 264.7 macrophages, Biochem. Biophys. Res. Commun., 272, 744, 10.1006/bbrc.2000.2859

Ikegami, 2001, The expression of prostaglandin E receptors EP2 and EP4 and their different regulation by lipopolysaccharide in C3H/HeN peritoneal macrophages, J. Immunol., 166, 4689, 10.4049/jimmunol.166.7.4689

Shinomiya, 2001, Regulation of TNF-α and interleukin-10 production by prostaglandins I(2) and E(2): studies with prostaglandin-receptor-deficient mice and prostaglandin-E-receptor subtype-selective synthetic agonists, Biochem. Pharmacol., 61, 1153, 10.1016/S0006-2952(01)00586-X

Hinz, 2000, Salicyclate metabolites inhibit cyclooxygenase-2-dependent prostaglandin E(2) synthesis in murine macrophages, Biochem. Biophys. Res. Commun., 274, 197, 10.1006/bbrc.2000.3123

Howell, 1993, Non-steroidal anti-inflammatory drugs as inhibitors of periodontal disease progression, Crit. Rev. Oral Biol. Med., 4, 177, 10.1177/10454411930040020301

Birkedal-Hansen, 1993, Role of cytokines and inflammatory mediators in tissue destruction, J. Periodontal Res., 28, 500, 10.1111/j.1600-0765.1993.tb02113.x

Noguchi, 2000, Cyclooxygenase-2-dependent prostaglandin production by peripheral-blood monocytes stimulated with lipopolysacharides isolated from periodontopathogenic bacteria, J. Periodontol., 71, 1575, 10.1902/jop.2000.71.10.1575

Dempke, 2001, Cyclooxygenase-2: a novel target for cancer chemotherapy?, J. Cancer Res. Clin. Oncol., 127, 411, 10.1007/s004320000225

Chulada, 2000, Genetic disruption of Ptgs-1, as well as Ptgs-2, reduces intestinal tumorigenesis in Min mice, Cancer Res., 60, 4705

Sumitani, 2001, Specific inhibition of cyclooxygenase-2 results in inhibition of proliferation of oral cancer cell lines via suppression of prostaglandin E2 production, J. Oral Pathol. Med., 30, 41, 10.1034/j.1600-0714.2001.300107.x

Gately, 2000, The contributions of cyclooxygenase-2 to tumor angiogenesis, Cancer Metastasis Rev., 19, 19, 10.1023/A:1026575610124

Narumiya, 1986, Site and mechanism of growth inhibition by prostaglandins. I. Active transport and intracellular accumulation of cyclopentenone prostaglandins, a reaction leading to growth inhibition, J. Pharmacol. Exp. Ther., 239, 500

Nishio, 2000, Molecular identification of a rat novel organic anion transporter moat1, which transports prostaglandin D(2), leukotriene C(4) and taurocholate, Biochem. Biophys. Res. Commun., 275, 831, 10.1006/bbrc.2000.3377

Kliewer, 1998, The nuclear receptor PPAR-γ – bigger than fat, Curr. Opin. Genet. Dev., 8, 576, 10.1016/S0959-437X(98)80014-2

Spiegelman, 1998, PPAR-γ: adipogenic regulator and thiazolidinedione receptor, Diabetes, 47, 507, 10.2337/diabetes.47.4.507

Harris, 2001, The nuclear receptor PPAR-γ is expressed by mouse T lymphocytes and PPAR-γ agonists induce apoptosis, Eur. J. Immunol., 31, 1098, 10.1002/1521-4141(200104)31:4<1098::AID-IMMU1098>3.0.CO;2-I

Clark, 2000, The nuclear receptor PPAR-γ and immunoregulation: PPAR-γ mediates inhibition of helper T-cell responses, J. Immunol., 164, 1364, 10.4049/jimmunol.164.3.1364

Satoh, 1999, Prostaglandin J2 and its metabolites promote neurite outgrowth induced by nerve growth factor in PC12 cells, Biochem. Biophys. Res. Commun., 258, 50, 10.1006/bbrc.1999.0587

Vaidya, 1999, 15-deoxy-Δ12,14-prostaglandin J2 inhibits the β2-integrin-dependent oxidative burst: involvement of a mechanism distinct from peroxisome proliferator-activated receptor γ ligation, J. Immunol., 163, 6187, 10.4049/jimmunol.163.11.6187

Rossi, 2000, Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IκB kinase, Nature, 403, 103, 10.1038/47520

Hirai, 2001, Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils and basophils via seven-transmembrane receptor CRTH2, J. Exp. Med., 193, 255, 10.1084/jem.193.2.255

Castrillo, 2000, Inhibition of IκB kinase and IκB phosphorylation by 15-deoxy-Δ(12,14)-prostaglandin J(2) in activated murine macrophages, Mol. Cell. Biol., 20, 1692, 10.1128/MCB.20.5.1692-1698.2000

Padilla, 2000, Peroxisome proliferator activator receptor γ agonists and 15-deoxy-Δ(12,14)(12,14)-PGJ(2) induce apoptosis in normal and malignant B-lineage cells, J. Immunol., 165, 6941, 10.4049/jimmunol.165.12.6941

Nakajima, 2001, Endogenous PPAR-γ mediates anti-inflammatory activity in murine ischemia–reperfusion injury, Gastroenterology, 120, 460, 10.1053/gast.2001.21191

Su, 1999, A novel therapy for colitis utilizing PPAR-γ ligands to inhibit the epithelial inflammatory response, J. Clin. Invest., 104, 383, 10.1172/JCI7145

Kawahito, 2000, 15-deoxy-Δ(12,14)-PGJ(2) induces synoviocyte apoptosis and suppresses adjuvant-induced arthritis in rats, J. Clin. Invest., 106, 189, 10.1172/JCI9652

Couturier, 1999, Interleukin-1β induces type-II-secreted phospholipase A(2) gene in vascular smooth muscle cells by a nuclear factor κB and peroxisome proliferator-activated receptor-mediated process, J. Biol. Chem., 274, 23085, 10.1074/jbc.274.33.23085

Meade, 1999, Peroxisome proliferators enhance cyclooxygenase-2 expression in epithelial cells, J. Biol. Chem., 274, 8328, 10.1074/jbc.274.12.8328

Zhang, 2001, Differential regulation of chemokine gene expression by 15-deoxy-Δ12,14 prostaglandin J2, J. Immunol., 166, 7104, 10.4049/jimmunol.166.12.7104

Wilmer, 2001, A cyclopentenone prostaglandin activates mesangial MAP kinase independently of PPAR-γ, Biochem. Biophys. Res. Commun., 281, 57, 10.1006/bbrc.2001.4301

Jozkowicz, 2001, Prostaglandin-J2 induces synthesis of interleukin-8 by endothelial cells in a PPAR-γ-independent manner, Prostaglandins Other Lipid Mediat., 66, 165, 10.1016/S0090-6980(01)00155-1

Thieringer, 2000, Activation of peroxisome proliferator-activated receptor γ does not inhibit IL-6 or TNF-α responses of macrophages to lipopolysaccharide in vitro or in vivo, J. Immunol., 164, 1046, 10.4049/jimmunol.164.2.1046

Takashima, 2001, PPAR-γ ligands inhibit growth of human esophageal adenocarcinoma cells through induction of apoptosis, cell-cycle arrest and reduction of ornithine decarboxylase activity, Int. J. Oncol., 19, 465

Fuhrer, 2001, A nuclear receptor in thyroid malignancy: is PAX8/PPAR-γ the Holy Grail of follicular thyroid cancer?, Eur. J. Endocrinol., 144, 453, 10.1530/eje.0.1440453

Ahn, 1998, The role of c-Myc and heat-shock protein 70 in human hepatocarcinoma Hep3B cells during apoptosis induced by prostaglandin A2/Δ12-prostaglandin J2, Biochim. Biophys. Acta., 1448, 115, 10.1016/S0167-4889(98)00113-X

Vanaja, 2000, Tumor prevention and antitumor immunity with heat-shock protein 70 induced by 15-deoxy-Δ12,14-prostaglandin J2 in transgenic adenocarcinoma of mouse prostate cells, Cancer Res., 60, 4714

Sarraf, 1999, Loss-of-function mutations in PPAR-γ associated with human colon cancer, Mol. Cell, 3, 799, 10.1016/S1097-2765(01)80012-5

DuBois, 1998, The nuclear eicosanoid receptor, PPAR-γ, is aberrantly expressed in colonic cancers, Carcinogenesis, 19, 49, 10.1093/carcin/19.1.49

Demetri, 1999, Induction of solid tumor differentiation by the peroxisome proliferator-activated receptor γ ligand troglitazone in patients with liposarcoma, Proc. Natl. Acad. Sci. U. S. A., 96, 3951, 10.1073/pnas.96.7.3951

Xin, 1999, Peroxisome proliferator-activated receptor γ ligands are potent inhibitors of angiogenesis in vitro and in vivo, J. Biol. Chem., 274, 9116, 10.1074/jbc.274.13.9116

Marx, 1998, Peroxisome proliferator-activated receptor γ activators inhibit gene expression and migration in human vascular smooth muscle cells, Circ. Res., 83, 1097, 10.1161/01.RES.83.11.1097